AQEMIA’s Post

🌟 Sanofi x AQEMIA: Redefining the way new medicines are developed, atom by atom 🌟 Together, we aim to redefine the way new medicines are developed, accelerating the delivery of innovative treatments to patients. By combining Sanofi’s R&D expertise with AQEMIA’s physics-powered algorithms, our partnership is pioneering the design and optimization of molecules with unparalleled speed and precision. In this conversation, Matt Truppo (Sanofi’s Global Head of Research Platforms & Computational R&D) and Maximilien Levesque (AQEMIA CEO & Cofounder) discuss how this unique collaboration is accelerating progress in drug discovery. Watch the full discussion below ⤵ #Biotech #GenAI #DrugDiscovery

𝗔𝗤𝗘𝗠𝗜𝗔 𝗶𝘀 𝗲𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴, 𝗮𝗻𝗱 𝘄𝗲'𝗿𝗲 𝗵𝗶𝗿𝗶𝗻𝗴! 🚀 🌟 We're looking for talented individuals to join us on our mission to accelerate drug discovery and bring transformative medicines to patients 💊 Here’s a glimpse of some key roles we’ve just opened: ▶ Program Leader  ▶ Medicinal Chemist ▶ Senior Drug Hunter ▶ DevSecOps Engineer If you're passionate about innovation in healthcare and want to be part of a cutting-edge team, check out the details ➡ https://lnkd.in/e2raz4Zd Join us and shape the future of medicine! #Hiring #DrugHunter #MedicinalChemist #ComputationalChemist #ProgramLeader #DrugDiscovery  ↔ Nicolas Serva

"It's as if we had a physics professor teaching physics to our generative AI. The AI invents drug candidates, and the professor tells it whether they are stupid or interesting, and if so to continue in that direction until we are satisfied enough with the molecules found by the #generativeAI to have them manufactured and then tested in the laboratory" explains Maximilien Levesque, our CEO & Cofounder. Building on a unique blend of theoretical physics and chemistry, we’re leveraging advanced technology to accelerate the development of breakthrough treatments. Curious about how a drug actually stops a disease? 💊 Check out the full Brut. video where Emmanuelle Martiano Rolland breaks it down ↘ https://lnkd.in/eAWZEBPT Thanks Tibor for visiting us and glad to share this vision of healthcare innovation with Bpifrance, whose support has been invaluable!  #DrugDiscovery #AI #Physics #TechBio #Big10

{Press Review} : AI Feature for l'Opinion : the 100 who are powering AI in Europe In an interview with l'Opinion, AQEMIA's co-founder and COO, Emmanuelle Martiano Rolland, shared insights into our mission to combine generative AI with theoretical physics in the quest for breakthrough cancer treatments. The article also highlights our partnership with Sanofi and how our technology is already showing promising results in preclinical studies. While we’re proud of our French roots 🇫🇷 , our mission is global: advancing research and therapies to benefit patients worldwide 🌎 Thank you l'Opinion and Grégoire Arnould-Cordier for this insightful conversation ⤵  https://lnkd.in/e7eKcRVu #AI #DrugDiscovery #Biotech #Healthcare #lOdysseedelIA

Today, we’re giving you a behind-the-scenes look at our team’s experience last week at #RICT2024, the International Conference on Medicinal Chemistry held in Bordeaux, focusing on 'Interfacing Chemical Biology and Drug Discovery.' Congratulations to Nicolas George for being invited to chair two sessions: Next Generation Cancer Therapeutics, and First Disclosures of Clinical Candidates and Case Studies, where a potent and selective antagonist of CCR6 was disclosed, alongside novel c-MET inhibitors 🧬. There were in particular some leading talks on PROTACs and computational strategies to design RNA-targeting small molecules, tackling the highly flexible and elusive nature of RNA targets . At AQEMIA, we are excited to be at the forefront of combining generative AI with deep physics and medicinal chemistry to discover new drugs for unmet medical needs 💊 . A big thank you to the other team members who were also present at the event: Salete Baptista, Alessio Prunotto, Piermichele Kobauri 🌟 #DrugDiscovery #MedicinalChemistry #MachineLearning #Biotech #AQEMIA #CancerTherapeutics cc Société de Chimie Thérapeutique SCT

🌟 Welcome to The Jungle 🌟 Ever wondered what it is like to be a Drug hunter or a Software engineer at AQEMIA? 🎥 Our page now features insightful videos explaining various roles at AQEMIA, giving you a glimpse behind the scenes of how we operate. Also, we are growing fast, already numbering around sixty, and we are recruiting for a wide range of positions to roll out our mission to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Below our COO & co-founder Emmanuelle Martiano Rolland discusses AQEMIA’s purpose and what differentiates us from other biotech companies. 🔗 Link to our Welcome to the Jungle page in the comments ⬇️ #welcometothejungle #AQEMIA #drugdiscovery #careeropportunities #biotech #hiring #MachineLearning #DrugHunter CC Marina Moisan Marion Birolini our HR stars🌟